Skip to main content
Equibles

MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Position in MYGN — Myriad Genetics Inc

CIK 912938 Boston, MA
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$758,584
+$136,928 QoQ
Shares Held
132,852
-3.8% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 196 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 83% Shared 17% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $7,261,067,923 across 19 Diagnostics & Research names. MYGN ranks #17 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 WAT
Waters Corp /De/
 4,625,035 $1,734,573,121
2 TMO
Thermo Fisher Scientific Inc.
 2,965,714 $1,486,890,367
3 A
Agilent Technologies, Inc.
 10,010,867 $1,329,743,461
4 DHR
Danaher Corp /De/
 3,878,641 $738,803,535
5 NTRA
Natera, Inc.
 1,971,391 $535,134,085
6 ICLR
Icon PLC
 2,105,171 $365,689,252
7 ILMN
Illumina, Inc.
 1,744,209 $306,684,265
8 IDXX
Idexx Laboratories Inc /De
 336,986 $177,402,907

All Filings in MYGN

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $758,584 132,852
2026-03-31 $621,656 138,146
2025-12-31 $722,230 117,436